First clinical cases with new Magellan 6F robotic catheter announced

280

The initial clinical experience is to be presented at the Global Embolization Symposium and Technologies US meeting (GEST US,1–4 May, San Francisco, USA), a press release says.

Hansen has announced the successful completion of the world’s first clinical procedures using the Magellan 6F robotic catheter. Marc Sapoval and Olivier Pellerin treated three patients with the 6F catheter over the span of two days at Hôpital Européen Georges Pompidou (APHP) in Paris, France. The cases included two uterine fibroid embolizations and a transarterial chemoembolization (TACE) procedure for liver metastasis of colon cancer.

The three cases performed last week were the first in a 25 patient study at Pompidou Hospital (APHP) to assess the use of the new Magellan 6F robotic catheter in a variety of embolization procedures.

The Magellan 6F robotic catheter is the latest addition to the growing family of catheters for use with the Magellan Robotic System. The 6F catheter’s design provides for precise robotic navigation and control in a single 6F outer diameter catheter, and enables use of the Magellan Robotic System in smaller vessels in the peripheral vasculature. The Magellan 6F robotic catheter and accessories have received 510(k) clearance in the US, and are pending CE mark.

“We are pleased to have completed the world’s first procedures with the Magellan 6F Catheter. With this study, we will explore the use of intravascular robotics in a wide variety of peripheral vascular embolization procedures, including therapies involving cancer treatment and women’s and men’s health,” explains Sapoval. “Navigation with this robotic catheter is very controlled, particularly in tortuous anatomy; and the Magellan Robotic System provided an extremely stable platform to support the precise and targeted delivery of therapeutic agents.”

Hansen will be conducting product demonstrations with the new Magellan 6F robotic catheter at the GEST US meeting at Booth 210. Sapoval will discuss his initial clinical experiences with Magellan on Thursday, 1 May at 10:40am in a talk titled “Robotic assisted embolization: Early human experience.”

Additionally, Olivier Pellerin (Hôpital Pompidou) and Mohamad Hamady (St Mary’s Hospital in London, UK) will share their clinical experiences with the Magellan Robotic System at a breakfast symposium at 7:00am on Saturday, 3 May titled “Clinical update on robotic assisted embolization: What you need to know.”